FDA Inspection 1035275 — Blaise Baxter, M.D.
The FDA completed an inspection of Blaise Baxter, M.D. on Nov 29, 2017 in Chattanooga, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 29, 2017
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Chattanooga, TN (United States)
Additional Details
Clinical Investigator (CI)